Teradyne, Inc.
—- Market cap
- —
- Debt
- —
- Cash
- −$293.75M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: TER stock price vs DHR: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DHR's multiple
Needs DHR P/E.
Implied fair value · at TER's multiple
Needs TER P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
TERADYNE, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
DANAHER CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
APPLIED MATERIALS INC /DE
TER vs AMAT
INTEL CORP
TER vs INTC
LAM RESEARCH CORP
TER vs LRCX
KLA CORP
TER vs KLAC
SKYWORKS SOLUTIONS, INC.
TER vs SWKS
LATTICE SEMICONDUCTOR CORP
TER vs LSCC
AGILENT TECHNOLOGIES, INC.
TER vs A
ILLUMINA, INC.
TER vs ILMN
JOHNSON & JOHNSON
TER vs JNJ
ABBOTT LABORATORIES
TER vs ABT
LOEWS CORP
TER vs L
BERKSHIRE HATHAWAY INC
TER vs BRK-B
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe TER can sustain very high growth and premium returns long enough to justify a 106.0x P/E, then hold or wait for a materially better entry point; otherwise, the valuation gap versus DHR argues for caution because the current price implies far more upside than DHR and DCF ranges support.
TER trades at a large premium to DHR on both earnings and revenue-based valuation, which is not supported by DHR-implied valuation range. The current price of $367.69 sits above DHR implied range and far above the DCF range, indicating the market is pricing in a much richer growth and quality profile than DHR.
Supporting Metrics